Big data analysis of influenza vaccination and liver cancer risk in hypertensive patients: insights from a nationwide population-based cohort study.

Bibliographic Details
Title: Big data analysis of influenza vaccination and liver cancer risk in hypertensive patients: insights from a nationwide population-based cohort study.
Authors: Chiu, Chun-Chih, Hao, Wen-Rui, Lin, Kuan-Jie, Chen, Chun-Chao, Yang, Tsung-Yeh, Fang, Yu-Ann, Yang, Tsung-Lin, Lai, Yu-Hsin, Chen, Ming-Yao, Hsu, Min-Huei, Lin, Cheng-Hsin, Hsiu, Hsin, Chen, Huan-Yuan, Cheng, Tzu-Hurng, Chen, Nai-Hsuan, Liu, Ju-Chi
Source: BMC Gastroenterology; 2/24/2025, Vol. 25 Issue 1, p1-11, 11p
Subject Terms: INFLUENZA vaccines, LIVER cancer, CANCER vaccines, HYPERTENSION, DISEASE risk factors
Abstract: Background: previous studies have indicated that influenza vaccination may be associated with reduced risks of certain types of cancer. However, the protective effect of influenza vaccination against primary liver cancer in individuals with hypertension remains unclear. Methods: In this cohort study, 37,022 patients over 55 years of age who received a diagnosis of hypertension at any time between January 1, 2001, and December 31, 2012, were enrolled from the National Health Insurance Research Database. The patients were divided into a vaccinated and an unvaccinated group. Categorical and continuous variables were analyzed using the chi-square test and t test, respectively, and the correlation between influenza vaccination and liver cancer in patients with hypertension was analyzed using time-varying COX model. Propensity score method was performed to reduce selection bias. Results: Compared with the unvaccinated group, the vaccinated group had a significantly lower incidence of liver cancer (hazard ratio = 0.56, 95% confidence interval = 0.46–0.64; p <.001). In addition, a protective effect was observed regardless of sex, age, or comorbidities. Besides, the association was dose-dependent which could be noted when patients were stratified based on the total number of vaccinations. The adjusted HRs for patients receiving 1, 2 to 3, and ≥ 4 vaccinations during the follow-up period were 0.60 (0.51–0.78), 0.48 (0.38–0.65), and 0.39(0.30–0.51), respectively. Conclusions: In summary, influenza vaccination is linked to a decreased risk of liver cancer in individuals with hypertension. However, unmeasurable confounders may have been present in the analysis. [ABSTRACT FROM AUTHOR]
Copyright of BMC Gastroenterology is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:1471230X
DOI:10.1186/s12876-025-03665-w
Published in:BMC Gastroenterology
Language:English